Cargando…
How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
Coronavirus disease 2019 (COVID-19) has rapidly spread all over the world with a very high rate of mortality. Different symptoms developed by COVID-19 infection and its impacts on various organs of the human body have highlighted the importance of both coinfections and superinfections with other pat...
Autores principales: | Azimirad, Masoumeh, Noori, Maryam, Raeisi, Hamideh, Yadegar, Abbas, Shahrokh, Shabnam, Asadzadeh Aghdaei, Hamid, Bentivegna, Enrico, Martelletti, Paolo, Petrosillo, Nicola, Zali, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710593/ https://www.ncbi.nlm.nih.gov/pubmed/34966759 http://dx.doi.org/10.3389/fmed.2021.775063 |
Ejemplares similares
-
Rapid-format recombinant antibody-based methods for the diagnosis of Clostridioides difficile infection: Recent advances and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2022) -
Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2023) -
Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
por: Raeisi, Hamideh, et al.
Publicado: (2022) -
Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of Clostridioides difficile
por: Raeisi, Hamideh, et al.
Publicado: (2023) -
Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro
por: Azimirad, Masoumeh, et al.
Publicado: (2022)